Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-21-024363
Filing Date
2021-02-16
Accepted
2021-02-16 17:08:15
Documents
1
Group Members
5AM CO-INVESTORS IV, L.P.5AM OPPORTUNITIES I (GP), LLC5AM OPPORTUNITIES I, L.P.5AM PARTNERS IV, LLCANDREW J. SCHWABDR. JOHN D. DIEKMANDR. SCOTT M. ROCKLAGE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a21-6693_6sc13da.htm SC 13D/A 250701
  Complete submission text file 0001104659-21-024363.txt   252420
Mailing Address 2200 SAND HILL ROAD, SUITE 110 MENLO PARK CA 94025
Business Address 2200 SAND HILL ROAD, SUITE 110 MENLO PARK CA 94025 650-233-8600
5AM Ventures IV, L.P. (Filed by) CIK: 0001589315 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91159 | Film No.: 21640664
SIC: 2834 Pharmaceutical Preparations